New imaging agent could help doctors spot hidden tumors
NCT ID NCT04168528
First seen Jun 04, 2026 · Last updated Jun 14, 2026 · Updated 2 times
Summary
This study tested a new radioactive tracer (68GaNOTA-Anti-MMR-VHH2) that aims to make tumors visible on PET scans by targeting immune cells called macrophages that are often found around cancers. The trial involved 13 adults with advanced solid tumors, breast cancer, or melanoma. The main goals were to check the tracer's safety and see how well it highlights tumors compared to standard tissue analysis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Uz Brussel
Brussels, Brussels Capital, 1090, Belgium
Conditions
Explore the condition pages connected to this study.